Tolaney SM, Kalinsky K, Kaklamani V, D'Adamo DR, et al. Eribulin Plus Pembrolizumab in Patients With Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase 1b/2 Study. Clin Cancer Res 2021 Mar 16. pii: 1078-0432.CCR-20-4726.
PMID: 33727258